EP2665362A4 - Olefinhaltige kerntransportmodulatoren und verwendungen davon - Google Patents

Olefinhaltige kerntransportmodulatoren und verwendungen davon

Info

Publication number: EP2665362A4
Authority: EP; European Patent Office
Prior art keywords: olefin containing; nuclear transport; containing nuclear; transport modulators; modulators
Prior art date: 2011-01-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

EP12736172.3A

Other languages

English (en)

French (fr)

Other versions

EP2665362A1 (de

EP2665362B1 (de

Inventor

Vincent P Sandanayaka

Sharon Shacham

Sharon Shechter

Dilara Mccauley

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Karyopharm Therapeutics Inc

Original Assignee

Karyopharm Therapeutics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-01-17

Filing date

2012-01-16

Publication date

2014-06-18

2012-01-16 Application filed by Karyopharm Therapeutics Inc filed Critical Karyopharm Therapeutics Inc

2013-11-27 Publication of EP2665362A1 publication Critical patent/EP2665362A1/de

2014-06-18 Publication of EP2665362A4 publication Critical patent/EP2665362A4/de

2016-03-30 Application granted granted Critical

2016-03-30 Publication of EP2665362B1 publication Critical patent/EP2665362B1/de

Status Ceased legal-status Critical Current

2032-01-16 Anticipated expiration legal-status Critical

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Vascular Medicine (AREA)
Hematology (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Urology & Nephrology (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

EP12736172.3A 2011-01-17 2012-01-16 Olefinhaltige kerntransportmodulatoren und verwendungen davon Ceased EP2665362B1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201161433501P	2011-01-17	2011-01-17
PCT/US2012/021406 WO2012099807A1 (en)	2011-01-17	2012-01-16	Olefin containing nuclear transport modulators and uses thereof

Publications (3)

Publication Number	Publication Date
EP2665362A1 EP2665362A1 (de)	2013-11-27
EP2665362A4 true EP2665362A4 (de)	2014-06-18
EP2665362B1 EP2665362B1 (de)	2016-03-30

Family

ID=46516027

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP12736172.3A Ceased EP2665362B1 (de)	2011-01-17	2012-01-16	Olefinhaltige kerntransportmodulatoren und verwendungen davon

Country Status (7)

Country	Link
US (1)	US9303000B2 (de)
EP (1)	EP2665362B1 (de)
JP (2)	JP6106605B2 (de)
CN (1)	CN103402359B (de)
AU (1)	AU2012207565B2 (de)
CA (1)	CA2824808A1 (de)
WO (1)	WO2012099807A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8513230B2 (en)	2010-03-05	2013-08-20	Karyopharm Therapeutics, Inc.	Nuclear transport modulators and uses thereof
CN103402359B (zh) *	2011-01-17	2016-08-24	卡尔约药物治疗公司	含烯烃核运输调节剂及其用途
EP2736887B1 (de)	2011-07-29	2017-10-18	Karyopharm Therapeutics, Inc.	Hydrazidhaltige kerntransportmodulatoren und verwendungen davon
EP2736883B1 (de)	2011-07-29	2019-09-04	Karyopharm Therapeutics, Inc.	Nukleartransportmodulatoren und anwendungen davon
IN2014DN09434A (de)	2012-05-09	2015-07-17	Karyopharm Therapeutics Inc
CN103937872A (zh) *	2013-01-23	2014-07-23	上海市东方医院	Crm1在胃癌诊断与治疗中的应用
WO2014144772A1 (en)	2013-03-15	2014-09-18	Karyopharm Therapeutics Inc.	Methods of promoting wound healing using crm1 inhibitors
US11571455B2 (en)	2013-04-11	2023-02-07	Vanderbilt University	Methods and compositions for treating alcoholic liver disease
CN110386919B (zh)	2013-06-21	2023-07-14	卡尔约药物治疗公司	核转运调节剂及其用途
WO2014205393A1 (en) *	2013-06-21	2014-12-24	Karyopharm Therapeutics Inc.	Nuclear transport modulators and uses thereof
WO2015079031A1 (en) *	2013-11-28	2015-06-04	INSERM (Institut National de la Santé et de la Recherche Médicale)	Methods and pharmaceutical compositions for the treatment of beta-thalassemias
CN111484483B (zh)	2014-08-15	2023-05-26	卡尔约药物治疗公司	赛灵克斯的多晶型物
EP3397634A1 (de) *	2015-12-31	2018-11-07	Karyopharm Therapeutics, Inc.	Nukleartransportmodulatoren und verwendungen davon
US10526295B2 (en)	2015-12-31	2020-01-07	Karyopharm Therapeutics Inc.	Nuclear transport modulators and uses thereof
MA45244A (fr)	2016-06-13	2019-04-17	Cancer Research Tech Ltd	Pyridines substituées utilisées en tant qu'inhibiteurs de dnmt1
US11065230B2 (en)	2016-09-16	2021-07-20	Inserm (Institut National De La Sante Et De La Recherche Medicale)	Methods and pharmaceutical compositions for the treatment of systemic mastocytosis
US11602530B2 (en)	2016-11-28	2023-03-14	Biogen Ma Inc.	CRM1 inhibitors for treating epilepsy
EP3638287A4 (de)	2017-06-16	2021-03-17	Vanderbilt University	Verfahren und zusammensetzungen zur behandlung mikrobieller entzündungen
WO2019152731A1 (en) *	2018-01-31	2019-08-08	Alpine Androsciences, Inc.	Androgen receptor antagonists
WO2019232724A1 (en) *	2018-06-06	2019-12-12	Xw Laboratories, Inc.	Compounds as nuclear transport modulators and uses thereof
CN111606890A (zh)	2019-02-26	2020-09-01	微境生物医药科技(上海)有限公司	含丙烯酰基的核转运调节剂及其用途
MX2021013211A (es)	2019-05-01	2022-03-11	Karyopharm Therapeutics Inc	Proceso para la preparacion de inhibidores de xpo1 y productos intermedios para su uso en la preparacion de inhibidores de xpo1.

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL97249A (en)	1990-02-23	1995-01-24	Takeda Chemical Industries Ltd	Compounds of 7,6,5,4-tetrahydrothiazole] B-5,4 [pyridine and compounds of 5,6-dihydro-H4-pyrrolo] D-3,2 [thiazole, their manufacture, and pharmaceutical compositions including or
US20030018025A1 (en)	1995-06-07	2003-01-23	Neurogen Corporation, Corporation Of The State Of Delaware	Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives: new classes of dopamine receptor subtype specific ligands
JP4054992B2 (ja) *	1996-04-25	2008-03-05	日産化学工業株式会社	エチレン誘導体および有害生物防除剤
AU736854B2 (en) *	1996-04-25	2001-08-02	Nissan Chemical Industries Ltd.	Ethylene derivatives and pesticides containing said derivatives
CN1964718A (zh) *	2004-06-03	2007-05-16	高山生物科学股份有限公司	来普霉素化合物
WO2006019020A1 (ja) *	2004-08-16	2006-02-23	Sankyo Company, Limited	置換されたウレア化合物
AU2006316079B2 (en)	2005-11-15	2012-03-29	Otsuka Pharmaceutical Co., Ltd.	Oxazole compound and pharmaceutical composition
JP2007210929A (ja) *	2006-02-09	2007-08-23	Sankyo Co Ltd	ウレア化合物を含有する医薬
PL1992618T3 (pl) *	2006-03-09	2012-06-29	Eisai R&D Man Co Ltd	Policykliczna pochodna cynamidowa
ZA200809148B (en)	2006-04-18	2010-01-27	Nippon Chemiphar Co	Activating agent for peroxisome proliferator activated receptor delta
WO2007137114A2 (en) *	2006-05-17	2007-11-29	Pioneer Hi-Bred International, Inc.	Artificial plant minichromosomes
JP4999923B2 (ja)	2006-06-13	2012-08-15	中国科学院上海薬物研究所	複素環非ヌクレオシド系化合物、抗ウィルス医薬組成物、及びウィルス性疾病治療薬物
PL2090570T3 (pl)	2006-09-05	2012-03-30	Kyowa Hakko Kirin Co Ltd	Pochodna imidazolu
EP1939180A1 (de)	2006-12-20	2008-07-02	sanofi-aventis	Heteroarylacrylamide und ihre Verwendung als Arzneimittel für die Stimulation der Expression der endothelialen NO-Synthase
US8513230B2 (en)	2010-03-05	2013-08-20	Karyopharm Therapeutics, Inc.	Nuclear transport modulators and uses thereof
CN103402359B (zh)	2011-01-17	2016-08-24	卡尔约药物治疗公司	含烯烃核运输调节剂及其用途
EP2736887B1 (de)	2011-07-29	2017-10-18	Karyopharm Therapeutics, Inc.	Hydrazidhaltige kerntransportmodulatoren und verwendungen davon
EP2736883B1 (de)	2011-07-29	2019-09-04	Karyopharm Therapeutics, Inc.	Nukleartransportmodulatoren und anwendungen davon
IN2014DN09434A (de)	2012-05-09	2015-07-17	Karyopharm Therapeutics Inc
US20160016916A1 (en)	2013-03-15	2016-01-21	Karyopharm Therapeutics Inc.	Exo Olefin-Containing Nuclear Transport Modulators and Uses Thereof
WO2014144772A1 (en)	2013-03-15	2014-09-18	Karyopharm Therapeutics Inc.	Methods of promoting wound healing using crm1 inhibitors
WO2014205393A1 (en)	2013-06-21	2014-12-24	Karyopharm Therapeutics Inc.	Nuclear transport modulators and uses thereof
CN110386919B (zh)	2013-06-21	2023-07-14	卡尔约药物治疗公司	核转运调节剂及其用途

2012
- 2012-01-16 CN CN201280010891.8A patent/CN103402359B/zh not_active Expired - Fee Related
- 2012-01-16 WO PCT/US2012/021406 patent/WO2012099807A1/en not_active Ceased
- 2012-01-16 JP JP2013549602A patent/JP6106605B2/ja not_active Expired - Fee Related
- 2012-01-16 EP EP12736172.3A patent/EP2665362B1/de not_active Ceased
- 2012-01-16 AU AU2012207565A patent/AU2012207565B2/en not_active Ceased
- 2012-01-16 US US13/350,864 patent/US9303000B2/en not_active Expired - Fee Related
- 2012-01-16 CA CA2824808A patent/CA2824808A1/en not_active Abandoned
2016
- 2016-12-22 JP JP2016249440A patent/JP2017110008A/ja not_active Withdrawn

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO2012099807A1 *

Also Published As

Publication number	Publication date
JP2014502641A (ja)	2014-02-03
JP2017110008A (ja)	2017-06-22
CA2824808A1 (en)	2012-07-26
AU2012207565A1 (en)	2013-08-22
EP2665362A1 (de)	2013-11-27
CN103402359B (zh)	2016-08-24
AU2012207565B2 (en)	2016-04-07
US20120258986A1 (en)	2012-10-11
CN103402359A (zh)	2013-11-20
HK1191512A1 (zh)	2014-08-01
EP2665362B1 (de)	2016-03-30
US9303000B2 (en)	2016-04-05
WO2012099807A1 (en)	2012-07-26
JP6106605B2 (ja)	2017-04-05

Legal Events

Date	Code	Title	Description
2013-10-25	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2013-11-27	17P	Request for examination filed	Effective date: 20130807
2013-11-27	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2014-04-23	DAX	Request for extension of the european patent (deleted)
2014-06-18	A4	Supplementary search report drawn up and despatched	Effective date: 20140515
2014-06-18	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 31/41 20060101ALI20140509BHEP Ipc: A01N 43/64 20060101AFI20140509BHEP
2014-08-01	REG	Reference to a national code	Ref country code: HK Ref legal event code: DE Ref document number: 1191512 Country of ref document: HK
2015-02-25	17Q	First examination report despatched	Effective date: 20150127
2015-08-06	REG	Reference to a national code	Ref country code: DE Ref legal event code: R079 Ref document number: 602012016301 Country of ref document: DE Free format text: PREVIOUS MAIN CLASS: A01N0043640000 Ipc: C07D0413140000
2015-08-18	GRAP	Despatch of communication of intention to grant a patent	Free format text: ORIGINAL CODE: EPIDOSNIGR1
2015-09-09	RIC1	Information provided on ipc code assigned before grant	Ipc: C07D 413/14 20060101AFI20150806BHEP Ipc: C07D 403/06 20060101ALI20150806BHEP Ipc: A61P 35/00 20060101ALI20150806BHEP Ipc: A61K 31/41 20060101ALI20150806BHEP Ipc: C07D 401/06 20060101ALI20150806BHEP Ipc: C07D 413/06 20060101ALI20150806BHEP Ipc: C07D 249/08 20060101ALI20150806BHEP Ipc: C07D 417/06 20060101ALI20150806BHEP
2015-09-16	INTG	Intention to grant announced	Effective date: 20150819
2015-12-21	GRAS	Grant fee paid	Free format text: ORIGINAL CODE: EPIDOSNIGR3
2016-02-26	GRAA	(expected) grant	Free format text: ORIGINAL CODE: 0009210
2016-03-30	AK	Designated contracting states	Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2016-03-30	REG	Reference to a national code	Ref country code: GB Ref legal event code: FG4D
2016-03-31	REG	Reference to a national code	Ref country code: CH Ref legal event code: EP
2016-04-15	REG	Reference to a national code	Ref country code: AT Ref legal event code: REF Ref document number: 785266 Country of ref document: AT Kind code of ref document: T Effective date: 20160415
2016-04-20	REG	Reference to a national code	Ref country code: IE Ref legal event code: FG4D
2016-05-12	REG	Reference to a national code	Ref country code: DE Ref legal event code: R096 Ref document number: 602012016301 Country of ref document: DE
2016-07-20	REG	Reference to a national code	Ref country code: NL Ref legal event code: FP
2016-07-25	REG	Reference to a national code	Ref country code: LT Ref legal event code: MG4D
2016-07-29	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160330 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160630 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160701 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160330
2016-08-15	REG	Reference to a national code	Ref country code: AT Ref legal event code: MK05 Ref document number: 785266 Country of ref document: AT Kind code of ref document: T Effective date: 20160330
2016-08-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160330 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160330 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160330 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160330
2016-08-31	REG	Reference to a national code	Ref country code: CH Ref legal event code: NV Representative=s name: ISLER AND PEDRAZZINI AG, CH
2016-10-11	REG	Reference to a national code	Ref country code: DE Ref legal event code: R082 Ref document number: 602012016301 Country of ref document: DE Representative=s name: MEISSNER BOLTE PATENTANWAELTE RECHTSANWAELTE P, DE Ref country code: DE Ref legal event code: R081 Ref document number: 602012016301 Country of ref document: DE Owner name: KARYOPHARM THERAPEUTICS, INC., NEWTON, US Free format text: FORMER OWNER: KARYOPHARM THERAPEUTICS, INC., NATICK, MASS., US
2016-10-14	REG	Reference to a national code	Ref country code: CH Ref legal event code: PCOW Free format text: NEW ADDRESS: 85 WELLS AVENUE, SUITE 210, NEWTON, MASSACHUSETTS 02459 (US)
2016-10-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160330 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160730 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160330
2016-11-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160330 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160330 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160801 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160330 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160330 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160330 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160330
2016-12-23	REG	Reference to a national code	Ref country code: FR Ref legal event code: CA Effective date: 20161118
2016-12-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160330 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160330
2017-01-03	REG	Reference to a national code	Ref country code: DE Ref legal event code: R097 Ref document number: 602012016301 Country of ref document: DE
2017-01-25	REG	Reference to a national code	Ref country code: FR Ref legal event code: PLFP Year of fee payment: 6
2017-01-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160330
2017-02-03	PLBE	No opposition filed within time limit	Free format text: ORIGINAL CODE: 0009261
2017-02-03	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT
2017-03-08	26N	No opposition filed	Effective date: 20170103
2017-05-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160330
2017-06-02	REG	Reference to a national code	Ref country code: HK Ref legal event code: GR Ref document number: 1191512 Country of ref document: HK
2017-09-29	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160330
2017-11-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170116
2018-01-25	REG	Reference to a national code	Ref country code: FR Ref legal event code: PLFP Year of fee payment: 7
2018-09-28	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: MT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170116
2018-10-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160330
2019-04-30	PGFP	Annual fee paid to national office [announced via postgrant information from national office to epo]	Ref country code: DE Payment date: 20190129 Year of fee payment: 8 Ref country code: NL Payment date: 20190126 Year of fee payment: 8 Ref country code: FR Payment date: 20190125 Year of fee payment: 8 Ref country code: GB Payment date: 20190128 Year of fee payment: 8 Ref country code: IE Payment date: 20190128 Year of fee payment: 8 Ref country code: CH Payment date: 20190204 Year of fee payment: 8
2019-06-28	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20120116
2019-08-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160330
2019-10-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: CY Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20160330
2019-11-29	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: MK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160330
2020-03-31	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160330
2020-08-01	REG	Reference to a national code	Ref country code: DE Ref legal event code: R119 Ref document number: 602012016301 Country of ref document: DE
2020-08-31	REG	Reference to a national code	Ref country code: CH Ref legal event code: PL
2020-09-02	REG	Reference to a national code	Ref country code: NL Ref legal event code: MM Effective date: 20200201
2020-09-23	GBPC	Gb: european patent ceased through non-payment of renewal fee	Effective date: 20200116
2020-10-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200801 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200131 Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200201 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200116
2020-11-30	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200131 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200131
2021-01-29	PG25	Lapsed in a contracting state [announced via postgrant information from national office to epo]	Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20200116

Publication	Publication Date	Title
ZA202004892B (en)	2023-03-29	Nuclear transport modulators and uses thereof
SG10201609097PA (en)	2016-12-29	Nuclear transport modulators and uses thereof
ZA201401223B (en)	2022-03-30	Hydrazide containing nuclear transport modulators and uses thereof
ZA201307261B (en)	2014-12-23	Active materials for electro-optic devices and electro-optic devices
ZA201308930B (en)	2015-02-25	Nitrogen containing compounds and their use
ZA201407736B (en)	2016-05-25	Flexible containers
GB2502467B (en)	2016-12-14	Object carrying device
ZA201300693B (en)	2015-10-28	Tube-feed packages and methods for using same
PL2904124T3 (pl)	2017-06-30	Urządzenie manipulacyjne
ZA201306675B (en)	2014-05-28	Transport and presentation crate
EP2720664A4 (de)	2014-11-12	Lagerungs- und mischflasche
PL2668114T3 (pl)	2017-07-31	Urządzenie transportowe
PL2678208T3 (pl)	2014-08-29	Urządzenie transportowe
EP2933013A4 (de)	2016-09-14	Wasserstofffreisetzender film
EP2684415A4 (de)	2014-09-10	Verfahren und anordnungen zur handhabung einer trägerauswahl
ZA201400043B (en)	2015-08-26	Film and film packaging container
ZA201402761B (en)	2015-12-23	Packing system and use thereof
GB201105411D0 (en)	2011-05-11	Tight junctions modulators
PL2730642T3 (pl)	2019-07-31	Zbiornik biogazu
IL228268B (en)	2019-02-28	Methods and devices for treating biofouling
GB201108481D0 (en)	2011-07-06	Electro-optic modulator
GB201110698D0 (en)	2011-08-10	Devices and methods for emanatign liquids
GB201101093D0 (en)	2011-03-09	T Straps
EP2737394A4 (de)	2015-04-01	Handhabung von vorfällen
SG11201503986VA (en)	2015-06-29	Twistlock